A new study published in the Lancet medical journal on Friday has found hydroxychloroquine, the anti-malaria drug U.S. President Donald Trump said he’s been taking, could be linked to a higher death rate in COVID-19 patients. The study cautioned against using the drug to treat COVID-19 outside of clinical trials until there is conclusive data on the drug’s safety and efficacy. It was also not found to have any added benefit for COVID-19 patients, according to the study.
Health
Coronavirus outbreak: Study finds hydroxychloroquine may be tied to higher fatality risk for COVID-19 patients
More Videos
-
Aamjiwnaang First Nation declares state of emergency over benzene levels
-
Robot assists with direct spine surgery at London, Ont. hospital
-
Breaking down Ontario’s investment into primary health care providers
-
‘I Don’t Know Who You Are’: Canadian film explores HIV health care challenges
-
Health Matters: Breast cancer being found in younger women, study finds
-
Treatment from a female doctor lowers death rates, study finds
You are viewing an Accelerated Mobile Webpage.
View Original Article